Survivorship Care Plans in a Community Oncology Practice
NCT ID: NCT03028584
Last Updated: 2019-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2017-09-11
2018-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
NCT03935282
Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices
NCT03746314
Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study
NCT02111616
Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals
NCT05047575
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors
NCT01113554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Part 2: The research team will measure reach/maintenance (percentage of survivors with EHR-based survivorship care plans (SCPs) over a 9-month time period) and impact (pre/post survey of patient satisfaction and perceived care coordination).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinicians
Observe up to N=10 clinicians. Observations will include:
1. Oncology history and care plan development by clinicians including use of EHR technology to develop care plans and methods used to secure necessary information for care plan creation
2. Provision and coordination of survivorship care occurring during care team meetings, discussions among clinicians, and survivor visits with clinicians, especially visits in which a care plan is provided to a survivor
3. Clinician seeking survivorship related information or resources through use of technology or discussion with other clinicians
4. Survivorship work or tasks performed by the clinician including adding, modifying or extracting information from the EHR and adding or modifying information in the care plan
Survey
Subjects (cancer patients and clinicians) will complete up to 2 surveys.
Clinicians and Patients
Surveys of N=30 breast cancer, colon cancer, and prostate cancer patients. Subjects will complete 1st survey electronically in-clinic. Subjects will either be e-mailed or mailed a survey at 4 weeks.
Survey of clinicians will be sent via e-mail.
Survey
Subjects (cancer patients and clinicians) will complete up to 2 surveys.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey
Subjects (cancer patients and clinicians) will complete up to 2 surveys.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinicians: Are a physician, advanced practice practitioner, nurse, or equivalent
* Patients: Have a diagnosis of breast, colorectal, or prostate cancer for which and EHR-based SCP will be provided
* Patients: Have been treated with curative intent (e.g. surgery, chemotherapy and/or radiation therapy) for a Stage 1-3 cancer diagnosis
* Patients: Have received some part of active cancer treatment
* Patients: Have complete active treatment (defined as surgery, chemotherapy, and/or radiation therapy). HER2-based and endocrine therapies may be ongoing and do NOT need to have been completed
Exclusion Criteria
* Patients: Received all active cancer treatment elsewhere (e.g. "observation - only" patients)
* Patients: Have metastatic cancer
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AmyƩ Tevaarwerk, MD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Mary Sesto, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UW Cancer Center at ProHealth Care
Waukesha, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
UW Carbone Cancer Center Home Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-0760
Identifier Type: OTHER
Identifier Source: secondary_id
A534260
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH\MEDICINE\HEM-ONC
Identifier Type: OTHER
Identifier Source: secondary_id
UW16029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.